Both the cell level of EBV-specific HLA-E-restricted CD8+ T cells and the ratio of HLA-E*0103/0103 genotype are significantly higher in the EBNAhigh controls than MS patients or EBNAlow controls, suggesting a protective role of this EBV-specific CD8+ T cell subgroup. The gene discussed is CD8A; the disease is myeloid sarcoma.